References

  1. Gardener GJ et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion, 2012. [Citation] [RHeference]
  2. Scott SA et al. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes. Transfusion, 2014. [Citation] [RHeference]
  3. Lopez GH et al. A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype. Transfusion, 2016. [Citation] [RHeference]
  4. Quantock KM et al. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn. Transfusion, 2017. [Citation] [RHeference]
  5. McGowan EC et al. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang, 2017. [Citation] [RHeference]
  6. Lopez GH et al. Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor. Transfusion, 2017. [Citation] [RHeference]
  7. Lopez GH et al. A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms. Transfusion, 2018. [Citation] [RHeference]
  8. Schoeman EM et al. Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting. Transfusion, 2018. [Citation] [RHeference]
  9. J Morrison et al. Severe case of haemolytic disease of fetus and newborn occurring in baby who has inherited a novel RHD allele associated with a “partial” RhD positive phenotype Vox Sanguinis, 2019. — Abstract — [RHeference]